Skip to main content

15 June 2025

Last updated: Sunday 15 June 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The promise of episomal reprogramming

Sunday 24 November 2013

Interviewee/Contributor

Nick Seay

Organisation

Cellular Dynamics International Inc

Organisations

Forbion
MedImmune
The Pioneer Group
C4X Discovery Ltd
SSquared Consulting
Calliditas Therapeutics AB
Biocat
Novo Nordisk Biotech Fund
Purespring Therapeutics Ltd
TrakCel Ltd

Interviewees and Contributers

Gerald Kleymann
Tim Farries
Andrew Briggs and Timothy Brears
Bernd Muehlenweg
Nicholas McGranahan
Andreas Posch, Achim Plum and Richard Zahrl
Monika Paulė
Keith Flaherty
Moshik Cohen-Kutner and Niv Bachnoff
Jytte Lyngvig

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form